Home/Filings/4/0001209191-22-032839
4//SEC Filing

Woiwode Thomas 4

Accession 0001209191-22-032839

CIK 0001787297other

Filed

May 30, 8:00 PM ET

Accepted

May 31, 4:33 PM ET

Size

5.5 KB

Accession

0001209191-22-032839

Insider Transaction Report

Form 4
Period: 2022-05-26
Transactions
  • Award

    Director Stock Option (Right to Buy)

    2022-05-26+24,00024,000 total
    Exercise: $1.76Exp: 2032-05-25Common Stock (24,000 underlying)
Footnotes (1)
  • [F1]The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date.

Issuer

Passage BIO, Inc.

CIK 0001787297

Entity typeother

Related Parties

1
  • filerCIK 0001619294

Filing Metadata

Form type
4
Filed
May 30, 8:00 PM ET
Accepted
May 31, 4:33 PM ET
Size
5.5 KB